Indian Drugs
Indian government orders new drug-making standards following deaths overseas
The Indian government has mandated new drug manufacturing standards this year for the country's pharmaceutical companies, media reports said.
However, smaller firms are requesting a delay due to their existing financial burdens, as per a government notification as quoted by PTC News.
The Indian government tightened scrutiny after several deaths were reported overseas which were allegedly associated with drugs manufactured in India since 2022.
Aimed at revitalising the reputation of Indian pharmaceutical companies, the government's notification says as quoted by PTC News that "manufacturers must ensure the quality, safety, and efficacy of pharmaceutical products, assuming full responsibility for their suitability and compliance".
As per the notification, companies are required to conduct tests on ingredients and maintain adequate samples of intermediate and final products before marketing the finished product.
According to reports, the government has set a six-month deadline for major drug makers to address the concerns. Smaller firms have been given a year time to take the measures.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
